Autonomic Blockade and Endogenous Glucose Production

Summary

Autonomic Blockade and Endogenous Glucose Production is a clinical trial^[1].

Key Facts

• Autonomic Blockade and Endogenous Glucose Production is in the country of United States^[2].
• Autonomic Blockade and Endogenous Glucose Production's instance of is recorded as clinical trial^[3].
• Autonomic Blockade and Endogenous Glucose Production's start time is recorded as +2017-02-17T00:00:00Z^[4].
• Autonomic Blockade and Endogenous Glucose Production's end time is recorded as +2022-12-31T00:00:00Z^[5].
• Autonomic Blockade and Endogenous Glucose Production's sponsor is recorded as Vanderbilt University Medical Center^[6].
• Autonomic Blockade and Endogenous Glucose Production's number of participants is recorded as {'unit': '1', 'amount': '+12'}^[7].
• Autonomic Blockade and Endogenous Glucose Production's title is recorded as Acute Sympathetic Blockade and Endogenous Glucose Production^[8].
• Autonomic Blockade and Endogenous Glucose Production's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• Autonomic Blockade and Endogenous Glucose Production's ClinicalTrials.gov ID is recorded as NCT03028571^[10].
• Autonomic Blockade and Endogenous Glucose Production's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}^[11].
• Autonomic Blockade and Endogenous Glucose Production's research intervention is recorded as trimethaphan camsylate^[12].
• Autonomic Blockade and Endogenous Glucose Production's clinical trial phase is recorded as phase I clinical trial^[13].
• Autonomic Blockade and Endogenous Glucose Production's research site is recorded as Vanderbilt University Medical Center^[14].
• Autonomic Blockade and Endogenous Glucose Production's principal investigator is recorded as Italo O. Biaggioni^[15].
• Autonomic Blockade and Endogenous Glucose Production's study type is recorded as interventional study^[16].